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STAT3 regulates CD4+ T cell survival and differentiation. However, its effects on CD8+ T cells are not well understood. Here,
we show that in comparison to WT CD8+ T cells, STAT3-deficient CD8+ T cells exhibit a preactivated memory-like phenotype,
produce more IL-2, proliferate faster, and are more sensitive to activation-induced cell death (AICD). The enhanced proliferation
and sensitivity toAICD correlatedwith downregulation of class-O forkhead transcription factors (FoxO1, FoxO3A), p21waf1, p27KIP1,
Bcl-2, OX-40, and upregulation of FasL, Bax, and Bad. We examined whether STAT3-deficient CD8+ T cells can mount effective
response during herpes simplex virus (HSV-1) infection and experimental autoimmune uveitis (EAU). Compared to WT mice,
HSV-1-infected STAT3-deficient mice (STAT3KO) produced less IFN-𝛾 and virus-specific KLRG-1+ CD8+ T cells. STAT3KOmice
are also resistant to EAU and produced less IL-17-producing Tc17 cells. Resistance of STAT3KO to EAU correlated with marked
expansion of IL-10-producing regulatory CD8+ T cells (CD8-Treg) implicated in recovery from autoimmune encephalomyelitis.
Thus, increases of IL-6-induced STAT3 activation observed during inflammation may inhibit expansion of CD8-Tregs, thereby
impeding recovery from uveitis. These results suggest that STAT3 is a potential therapeutic target for upregulating CD8+ T cell-
mediated responses to viruses and suggest the successful therapeutic targeting of STAT3 as treatment for uveitis, derived, in part,
from promoting CD8-Treg expansion.
1. Introduction
STAT3 was originally described as an acute-phase response
factor (APRF) induced by IL-6 [1, 2], and many cytokines
produced by innate and adaptive immune cells including
IL-10, IL-21, IL-23, and IL-27 have now been shown to
induce STAT3 activation [3]. Understanding the myriad of
functions attributed to STAT3 in host immune responses
was limited by the fact that STAT3 deletion is embryonically
lethal [4]. To circumvent this limitation, mice with targeted
deletion of STAT3 in specific cell types have been generated
by use of the Cre-loxP recombination technology [4–8].
Mice with deletion of STAT3 in T cells generated by mating
STAT3fl/fl and LCK-Cre mice suggested that STAT3 mediates
IL-6-dependent T cell proliferation by preventing apoptosis
[9]. Subsequent studies using mice with targeted deletion
of STAT3 in the CD4 compartment using CD4-Cre mice
revealed that STAT3 inhibits IL-2 production and CD4+ T
cell proliferation by upregulating the expression of class-O
forkhead transcription factors (Fox O) and promoting the
sequestration of NF-𝜅B in the cytoplasm [10]. However, it
is not known whether STAT3 also regulates proliferation,
effector functions, and survival of CD8+ T cells.
In this study, we took advantage of the fact that the CD4
promoter is activated at theCD4/CD8double positive stage of
T cell development, and bymating the CD4-Cre and STAT3f/f
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mouse strains, we generated mice with deletion of STAT3 in
CD8, as well as, the CD4 T cell compartment. We describe
here studies characterizing the phenotype of STAT3-deficient
CD8+ T cell (CD8-STAT3KO) and the role STAT3 plays
in controlling CD8+ T cell proliferation, IL-2 production,
and activation-induced cell death (AICD) in vitro. We also
examined the effect of STAT3 in CD8+ T cell functions in
vivo, specifically in host immunity to HSV-1 infection and
autoimmune uveitis.
2. Materials and Methods
2.1. Animals and Reagents. Six-to-8-week old C57BL/6 mice
were purchased from Jackson Laboratory (Bar Harbor, ME).
CD4-CRE transgenic mice were purchased from Taconic
(Taconic, Hudson, NY). Dr. David Levy (New York Univer-
sity, New York, NY) provided the STAT3fl/fl mice. Mice with
loss of STAT3 in CD4 compartment (STAT3KO mice) were
generated by breeding CD4-CRE and Stat3fl/fl mouse strains
and had previously been described [7]. Animal care and use
were in compliance with NIH guidelines.
2.2. Herpes Simplex Virus 1 (HSV-1) Infection. Recombinant
HSV-1 (HSV-1) virus, RE-pICP0-EGFP [11], was kindly
provided by Paul R. Kinchington (University of Pittsburgh,
School of Medicine, Pittsburgh, Pennsylvania). HSV-1 was
grown in Vero cells. The intact virions were purified on
OptiPrep gradients according to the manufacturer’s instruc-
tions (Accurate Chemical & Scientific Corp., Westbury,
NY) and quantified as plaque forming units/mL (PFU/mL)
on Vero cell monolayer [11]. STAT3f/f (WT) and CD4-
STAT3KO mice (12 mice per group) were infected with
1.0 × 10
6 PFU/mL. Infectivity was established by detection
of tetramer positive HSV-1-specific CD8 T cells responsive
to HSV-1 gB tetramers. HSV-1 gB 498–505 peptide was syn-
thesized and HPLC-purified by Invitrogen. H-2Kb HSV-1 gB
(SSIEFARL/PE) tetramers were synthesized by NIH tetramer
facility, Emory University, Atlanta. GA. Dimer PE-H-2Kb: Ig
Fusion protein was purchased from BD Bioscience, and gB
peptide was loaded as recommended by the manufacturer’s
instructions.
2.3. Induction of Experimental Autoimmune Uveitis (EAU).
Agematched STAT3f/f mice or STAT3KOmice on aC57BL/6J
background were subcutaneously injected with 150 𝜇g of
bovine interphotoreceptor retinoid-binding protein (IRBP)
and 300 𝜇g of human IRBP peptide (amino acid residues 1–
20) permouse in 0.2mL emulsion (1 : 1 v/v with CFA contain-
ing Mycobacterium tuberculosis strain H37RA (2.5mg/mL).
Mice also received Bordetella pertussis toxin (0.3 𝜇g/mouse)
via intraperitoneal injection. The eyes were fixed in 10%
buffered formalin and serially sectioned in the vertical
pupillary-optic nerve plane. All sections were stained with
H&E. Disease severity was scored as described previously
[12].
2.4. CD8+ T cell Isolation and Cultures. CD8+ and CD4+ T
cells were isolated from lymph nodes (LN) and spleens of
6–8-week-old WT and STAT3KO mice. CD3 T cells were
enriched using CD3-cell-enrichment column by negative
selection. Further purification of CD8+ or CD4+ T cells was
performed using anti-CD4 or -CD8-Ab conjugated magnetic
beads (Miltenyi). In some experiments, naı¨ve CD8+ T cells
with CD62LHi and CD44Lo were sorted electronically on a
FACSAria II sorter (BD bioscience, CA). For the generation
of Tc0 cells, na¨ıve CD8+ T cells were cultured in plate-bound
anti-CD3 (10 𝜇g/mL) and soluble anti-CD28 Abs (3 𝜇g/mL)
(Bio X-cell,West Lebanon,NH). For the Tc1 cells, na¨ıve CD8+
T cells were cultured in plate-bound anti-CD3 (10 𝜇g/mL),
and soluble anti-CD28 Abs (3 𝜇g/mL), IL-12 (10 ng/mL), and
anti-IL-4 Abs (0𝜇g/mL) as previously described [13].
2.5. FACS Analysis and Intracellular Cytokine Staining.
Freshly isolated thymocytes, peripheral blood mononuclear
cells (PBMC), LN, or splenocytes were used directly for FACS
analysis. After washing in cold 1xPBS, the cells were stained
with antibodies against CD3, CD4, CD8, CD44, CD62L (BD
BioScience), or KLRG-1 (e-BioScience). Intracellular staining
assay for detection of cytokines or proteins was performed
using an intracellular cytokine staining Kit (BD Bioscience)
as described [13]. The cells were stimulated with PMA and
ionomycin for 4 hours with addition of brefeldin A (5𝜇g/mL)
after 2 hours of stimulation. FACS analysis was performed
on a Becton-Dickinson FACSCalibur (BD Pharmingen, San
Diego, CA).
2.6. Lymphocyte Proliferation and Apoptosis Assays. Purified
na¨ıve CD8+ T cells were cultured for 4 days under Tc0 or
Tc1 polarizing condition. After 36 h, cultures were pulsed
with [3H]-thymidine (0.5 𝜇Ci/10 𝜇L/well) for 12 additional
hours and analyzed as described [14]. For CFSE dilution
assay, cells were labeled as recommended by the manufac-
turer (Molecular Probe Inc., Eugene, OR) and as previously
described [13]. Annexin-V and 7-AAD apoptosis staining
kits were purchased from BD Bioscience, and assay was
performed as recommended by manufacturer. FACS analysis
was performed on a Becton-Dickinson FACSCalibur (BD
Harlingen, San Diego, CA).
2.7. Quantitative and Semiquantitative RT PCR Analyses.
Total RNA was extracted using the TRIzol reagent accord-
ing to the procedures recommended by the manufacturer
(Life Technologies, Gaithersburg, MD). All RNA samples
were digested with RNase-free DNase 1 (Life Technologies)
for 30min, purified by phenol/chloroform extractions, and
precipitated in 0.4M LiCl. RNA integrity was verified by
analysis of 18S and 28S ribosomal RNA expression on RNA
gels. RNA (10 𝜇g), SuperScript III Reverse Transcriptase
(Life Technologies, Gaithersburg, MD), and oligo (dT)
12−16
were used for first-strand synthesis as previously described
[15]. Samples were subjected to hot-start RT-PCR with
gene-specific primers and AmpliTaq Gold DNA polymerase
(Applied Biosystems, CA). Primers used for RT-PCR ampli-
fication are as follows. Amplification was conducted for 25
to 33 cycles of 30 s each at 95∘C, 60∘C, and 72∘C, followed
by a final 10 min extension at 72∘C. First-strand synthesis
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containing each mRNA sample but no reverse transcriptase
was performed to control for possible DNA contamination
of mRNAs used as target for PCR amplification; failure to
obtain RT-PCR products with any of the PCR amplimers
confirmed the absence of contaminating DNA templates.
PCR-amplified fragments were fractionated on agarose gels.
All cDNA preparations used were suitable substrates for
PCR amplification on the basis of efficient amplification
of a 𝛽-actin sequence. Real-time PCR was performed on
an ABI 7500 (Applied Biosystems), and PCR parameters
were as recommended for the TaqMan Universal PCR kit
Applied Biosystems. Primers and probes were purchased
from (Applied Biosystems).
2.8. Cytokine Analysis. Multiplex ELISA of supernatants for
cytokine secretion was performed using a commercial ELISA
kit R&D Systems, Minneapolis, MN.
2.9. Statistical Analyses. Results of statistical analyses were
expressed as mean ± SD and were analyzed by Student’s t-test
(∗𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗∗𝑃 < 0.0001, and NS denotes not
significant).
3. Results
3.1. STAT3-Deficient CD8+ T Cells Exhibit Activation Pheno-
type. The CD8+ T cell plays a central role in host immunity
against viruses and other intracellular pathogens. Following
pathogen recognition in context of MHC class I on antigen
presenting cells (APCs), the na¨ıve CD8+ T cell differentiates
into Tc1, Tc2, or Tc17 cells and begins expressing high levels
of KRLG-1 (killer lectin-like receptor subfamily G member
1) and the proinflammatory cytokine, IFN-𝛾 that mediate
their biological activities [16–19]. In this study, we analyzed
CD4-STAT3KO mice with targeted deletion of Stat3 in the
CD4 compartment to investigate the potential involvement
of STAT3 pathway in CD8+ T cell development and effector
functions. Since the functional CD4 promoter is active at
the CD4+CD8+ double positive stage of T cell development
[20, 21], we expected that high expression of the Cre protein
under the direction of a CD4 promoter element would lead to
deletion of the STAT3protein in bothCD4+ andCD8+ Tcells.
To confirm that STAT3 is indeed deleted in CD4-STAT3KO
T cells, we isolated CD4+ and CD8+ T cells from WT and
CD4-STAT3KO mice, purified the cells by cell sorting, and
prepared whole cell protein extracts. Western blot analysis
of whole cell extracts prepared from sorted CD8+ or CD4+
T cells revealed complete deletion of STAT3 in both CD4+
and CD8+ T cells (Figure 1(a)). We then isolated CD3+ T
cells from the blood, lymph nodes (LN), and spleen of the
WT and CD4-STAT3KO mice and investigated whether the
loss of STAT3 has disproportionate impact on CD4+ or CD8+
T cells. Analysis of the CD4+ T cell population showed a
significant decrease in the number of CD4+ T cells in the
CD4-STAT3KO compared to WT control (Figure 1(b)). The
marked decrease in the number of resting and unstimulating
CD4+ T cells in the CD4-STAT3KO mice is consistent with
the role of STAT3 inducing expression of FoxO1 and FoxO3a,
two class O forkhead transcription factors that contribute
to maintenance of CD4+ T cells in resting or quiescence
state [14]. Interestingly, we observed a significant increase
in CD8+ T cells in the CD4-STAT3KO compared to WT
mice (Figure 1(b)), suggesting that STAT3 may serve to
maintain CD8+ T cells at low levels under noninflammatory
condition. Consistentwith the differential effects of STAT3 on
resting CD4+ and CD8+ T cells, we observed an increase of
CD8 : CD4 ratio in STAT3KO compared toWT counterparts
(Figures 1(b) and 1(c)). In line with previous reports [14, 22],
the STAT3-deficient CD8+ T cells exhibited an activation
phenotype as indicated by the elevation of CD44 expression
(Figures 1(d) and 1(e)) and reduced CD62L (Figure 1(f)).
3.2. STAT3 Suppresses Proliferation and Protects CD8-
STAT3KO from IL-2-Induced AICD. Previous studies have
suggested complex roles of STAT3 in mechanisms that
regulate T cell proliferation [9] and that STAT3 and IL-2
signals exert mutually antagonistic effects on CD4+ T
cell proliferation and Th17 differentiation [23–26]. In this
study, we have investigated whether STAT3 plays a role
in regulating IL-2 production and proliferation of CD8+
T cells. We show here that STAT3-deficient CD8+ T cells
activated by stimulation with anti-CD3/anti-CD28 Abs
produced more IL-2 than WT CD8+ T cells as shown
by intracellular cytokine staining analysis and RT-qPCR
(Figures 2(a) and 2(b)). Results of CFSE dilution assay show
that the CD8-STAT3KO T cells divided much faster than
WT controls in response to TCR stimulation (Figure 2(c)).
This suggests that the loss of STAT3 signaling might have
contributed to the observed enhancement of IL-2 production
and cellular proliferation by the STAT3-deficient CD8+ T
cells. Surprisingly, intracellular cytokine staining analysis
showed that the frequency of IFN-𝛾-producing cells was
substantially decreased (67.3%) in the STAT3-deficient CD8+
T cells compared to 92.6% of the WT CD8+ T cells WT
(Figure 2(a); top panels). In contrast, loss of STAT3 in CD4+
T cells impaired Th17 development resulting in concomitant
expansion of IFN-𝛾-producing Th1 cells [7]. Thus, data
provided here suggests that IFN-𝛾 production by activated
CD8+ STAT3KO T cells is compromised.
T cells with high proliferative capacity produce high levels
of IL-2 and are highly susceptible to IL-2-induced AICD
[13]. We therefore examined whether the increase of IL-2
production renders the STAT3-deficient CD8+ T cells more
susceptible to AICD. We stimulated WT or STAT3-deficient
CD8+ na¨ıve T cells with anti-CD3/CD28Abs for 4 days under
Tc0 orTc1 polarization condition anddetermined the number
of T cells undergoing apoptosis by the Annexin-V staining
assay and FACS. Compared to WT Tc0 and Tc1 cells, higher
percentages of the STAT3-deficient CD8+ Tc0 or Tc1 cells
were undergoing apoptosis after 4 days of TCR activation
as revealed by Annexin-V staining (Figures 2(d) and 2(e)).
It is however important to emphasize that although similar
numbers of cells were used at the beginning of the study, after
culturing the cells for 4 days under Tc0 or Tc1 condition, the
Tc1 cells experiencedmore apoptosis.Thus, the total numbers
of viable cells acquired were not exactly the same for each
group. In addition, the STAT3-deficient CD8+ Tc0 or Tc1 cells
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Figure 1: STAT3-deficient CD8+ T cells exhibit a preactivated phenotype. (a) Purified CD4+ or CD8+ T cells derived from the spleen and LN
of control (STAT3f/f) and CD4-STAT3KO mice (CRECD4STAT3f/f) were analyzed by western blotting. (b) Eight-week-old WT or STAT3KO
mice were euthanized, and lymph nodes (LN) and spleen were harvested. Total CD4+ and CD8+ lymphocytes isolated from LN and spleen
were quantified on a Vi-CELL Cell Viability Analyzer (Beckman Coulter). (c) Freshly isolated T cells from the PBMC, LN, or spleen were
stained with Abs to CD3, CD4, or CD8 and analyzed by FACS. (d, e, f) Relative amounts of activated T cells in unstimulated thymocytes (d, e)
or spleen (f) of theWT or STAT3KOmice were determined by FACS analysis of CD44+ or CD62L+ T cells. Plots (d, e, f) were gated on CD3,
and numbers in quadrants represent percentage of T cells expressing CD4, CD8, or CD44. Data represent at least 3 independent experiments.
experienced higher necrotic cell death as indicated by higher
percentages of 7-AAD-positive cells (Figures 2(d) and 2(e)).
Nonetheless, these results suggest that STAT3may inhibit IL-
2-induced AICD and enhance the survival of CD8+ T cells by
constraining IL-2 production.
3.3. STAT3 Regulates Proapoptotic and Cell Cycle Regulatory
Genes of STAT3KO-CD8+ T Cells. STAT3 regulates prolifer-
ation and IL-2 production by CD4+ T cells by increasing the
expression of transcription factors and cell cycle regulatory
genes that maintain T cells in the quiescent state [14, 22].
We examined whether STAT3 also regulates the proliferation
and survival of CD8+ T cells by upregulating transcription
of genes that code for lymphocyte quiescence factors and/or
cell cycle regulatory proteins. We isolated na¨ıve CD8+ T
cells from the lymph nodes of WT or CD4-STAT3KO mice
and stimulated the cells with anti-CD3/CD28 Abs for 4 days
under Tc0 or Tc1 polarization condition. RNA was isolated
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Figure 2: STAT3 inhibits CD8+ T cell proliferation and protects T cells from apoptosis. (a, b) WT or STAT3KO naı¨ve T cells were stimulated
with anti-CD3/CD28 Abs under nonpolarizing condition for 4 days, and IL-2 or IFN-𝛾 expression was detected and quantified by the
intracellular cytokine staining assay (a) or RT-qPCR (b). (c) WT or STAT3KO T cells were stimulated in vitro with anti-CD3/CD28 Abs,
and CFSE dilution analysis was performed after 4 d stimulations. (d) Na¨ıve CD8+ T cells were cultured under Tc0 or Tc1 condition for 4 days
and stained with Annexin-V and 7-AAD. The cells undergoing apoptosis or necrosis were detected by FACS and cell counting using Vi-Cell
XR cell-viability analyzer. (e) The relative percentages of apoptotic and viable cells were derived from the data shown in Figure 2(d) and
statistically analyzed with Student’s t-test. Results are representative of 3 independent experiments.
from the cells, and RT-PCR or RT-qPCR analysis revealed
marked decrease of the transcription of foxO1 and foxO3a
genes in the STAT3-deficient CD8+ T cells compared to WT
CD8+ T cells (Figures 3(a) and 3(b)), consistent with the
involvement of these class O forkhead transcription factors
in regulating lymphocyte proliferation and quiescence [10].
The inverse correlation between the reduction in the levels
of FoxO1/FoxO3a mRNA transcripts and enhanced prolifer-
ation of STAT3-deficient CD8+ T cells supports the notion
that STAT3 regulates lymphocyte proliferation throughmod-
ulation of FoxO gene expression [14]. p21WAF1 and p27Kip1
are cyclin-dependent kinase inhibitors that regulate transit
of proliferating T cells through the G1 stage of the cell
cycle, and these cell cycle regulators are direct targets of
FoxO proteins [27]. We show here that the transcription of
p21WAF1 or p27Kip1 is also substantially reduced in STAT3-
deficient CD8+ T cells (Figure 3(c)), and this was accom-
panied by a corresponding increase in expression of cyclin
genes (Figure 3(c)). In addition, transcription of proapoptotic
genes (FasL, caspase 8, Bax, and Bad) was elevated in the
STAT3-deficient CD8+ Tc0 cells (Figures 3(d), and 3(e)),
while expression of antiapoptotic genes OX40 and Bcl-2
was decreased (Figures 3(d), 3(e), and 3(f)), consistent with
enhanced apoptosis observed in STAT3-deficient CD8+ T
cells (Figures 2(d), and 2(e)).
3.4. STAT3 Enhances CD8+ T Cell Effector Response to HSV-1.
Host immunity against viruses is mainly mediated by CD8+
T cells. It was therefore of interest to investigate whether
STAT3 signaling is required for this essential function of
cytotoxic T cells. We infected age-matched WT and CD4-
STAT3KOmice with the HSV-1 virus strain RE-pICP0-EGFP
[11] by intraperitoneal injection. On day 9 after the infection,
freshly isolated cells from the spleen were analyzed for the
expansion of HSV-1-specific CD8 response using an anti
HSV-1 gB tetramer [28]. Dose-dependent titration of the
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Figure 3: Enhanced proliferation and sensitivity to AICD of STAT3-deficient CD8+ T cells correlated with alterations in the expression of
proapoptotic, antiapoptosis, and cell-cycle regulatory genes. Naı¨ve CD8+ T cells were cultured for 4 days under Tc0 and Tc1 polarization
condition. RNAwas isolated and analyzed by RT-PCR (a, c, d) or qRT-PCR (b, e). (f) Naı¨ve CD8+ T cells were cultured for 4 days under non-
polarizing condition, and expression of OX-40 was detected by FACS. Numbers in quadrants represent percentage of CD8+ T cells expressing
OX-40. Data represent at least 3 independent experiments.
tetramer established a dilution of 1 : 2500 as the optimal
tetramer concentration of the tetramer for detection of HSV-
1-specific CD8+ T cells (Figure 4(a)), and this concentration
was used in all subsequent analyses. KLRG-1 (killer cell lectin-
like receptor subfamily G member 1) is a transmembrane
protein preferentially expressed in natural killer (NK) cells. It
is expressed following detection of virus epitopes in context
of MHC class I molecules and is therefore a marker of
virus-specific CD8+ T cell response. Although KLRG is
predominantly expressed on NK cells, its expression on
CD8+ T cells correlates with chronic viral infections. Thus,
increased expression of KLRG1 by virus-specific CD8 T cells
occurs mainly during persistent antigen stimulation [29].
Interestingly, we observed substantial increases in CD8+ T
cells in the infected CD4-STAT3KO mice as indicated in
the CD8/CD4 ratio (Figure 4(b)). Previous reports have
shown that the loss of STAT3 in CD4 compartment caused
enhanced proliferation of both CD4+ and CD8+ T cells
[14]. A consequence of the increased proliferative capacity
is the enhanced susceptibility to antigen-induced cell death
as indicated in this study and previous reports [7, 13].
It is notable that the CD4+ T cells appear to be more
susceptible to apoptosis as reflected by the relatively higher
levels of CD8 : CD4 ratios (Figure 4(b)). Despite the increased
frequency of CD8+ T cells, CD4-STAT3KO mice contained
significantly lower amounts of activated KLRG-1+ HSV-1-
responsive CD8+ T cells (Figure 4(c)). Analysis of CD62L in
the CD8+ cells after HSV-1 infection thus suggests that the
KO mice could mount an efficient primary response while
producing less memory cells (Figure 4(d)). In addition, the
STAT3-deficient CD8+ T cells produced much reduced levels
of the anti-inflammatory cytokine IFN-𝛾 (Figure 4(e)). It
is notable that a similar frequency of gB-tetramer positive
CD8 T cells are responding, but the virus-infectedWTCD8+
T cells express 2.366-fold more KRLG-1 compared to the
STAT3-deficient CD8+ T cells, suggesting that the knockout
cells are responding, but may be mostly SLEC (short lived
effector CD8 cells). These results suggest that activation of
STAT3 pathways may be required for the development of
a functionally fit CD8 effector T cell capable of mounting
effective immune responses against HSV-1.
3.5. STAT3 Inhibits IL-10-Producing Regulatory CD8+ T Cells
during Autoimmune Uveitis. CD4-STAT3KO mice do not
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Figure 4: STAT3KO mice are defective in generating HSV-1 specific CD8+ effector T cells in response to HSV-1 infection. (a–d) C57BL/6
mice were infected with HSV-1, and immune response to the virus was assessed by FACS analysis. (a) Virus-specific response was established
and assessed in the WT mouse by FACS using gB-tetramers. (b–d), Analysis of CD4+ and CD8+ T cell responses to HSV-1 (b), activated
virus-specific CD8+ T cells (c), and IFN-𝛾 production by the HSV-1-specific CD4/CD8 T cells (d). Cells were gated on CD8 (a, c) or CD3
(b, d), and numbers in quadrants represent percentage of tetramer positive CD8+ T cells or T cells expressing KLRG, CD62L, CD4, CD8, or
IFN-𝛾. Data represent at least 3 independent experiments.
develop EAU or EAE [7, 12]. To examine whether functional
defects in STAT3KOCD8+ T cells contribute to the resistance
to developing experimental autoimmune uveitis (EAU), we
immunized WT or CD4-STAT3KO mice with IRBP in CFA
as described in the methods section. At various time points
after immunization, the eyes were examined by fundoscopy,
and fundus images taken 21 days after induction of EAU show
the development of ocular pathology in the retina of the WT
but not the CD4-STAT3KO mice (Figure 5(a)). On day 21
after immunization, we also isolated PBMC and analyzed
CD4+ and CD8+ T cell responses by intracellular cytokine
staining assay.We focused on IL-17-expressing T cells because
Th17 cells are implicated in the induction and exacerbation
of EAU and human uveitis [7, 30]. We observed a significant
increase of IL-17-expressing CD4+ inWT (13.86%) compared
to the paucity of Th17 cells in CD4-STAT3KO (1.07%), and
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Figure 5: STAT3KO mice induce expansion of IL-10-producing regulatory CD8+ T cells during EAU. (a–d) WT or STAT3KO mice were
immunized with IRBP in CFA. (a) Fundus images taken on day-21 after immunization. (b) and 21 days after immunization. Freshly isolated
LN cells (21 days after immunization) were analyzed by the intracellular cytokine staining (b, c). CD3+ T cells were gated, and numbers in
quadrants indicate percentage of CD4+ or CD8+ T cells expressing IL-17A or IL-10. (d, e) CD8+ T cells were isolated from the LN bymagnetic
sorting, and RNA was analyzed for IL-10 expression by RT-qPCR (d) or RT-qPCR (e). Data represent at least 3 independent experiments.
this is consistent with the role of Th17 cells in mediating
EAU (Figure 5(a)) [7, 30]. In contrast,WTor STAT3-deficient
CD8+ T cells comprised 1.63% and 0.34% of the IL-17-
producing Tc17 cells, respectively (Figure 5(b)), suggesting
that CD8+ T cells may not be involved in mediating the
disease. It is however of note that IL-10-producing CD8+ T
cells have recently been shown to play an essential role in the
recovery from EAE [31], another CNS autoimmune disease
that shares essential attributes of the immune-pathogenic
mechanisms with EAU [32]. We therefore isolated cells from
the spleen and lymph nodes of WT or CD4-STAT3KO mice
21 days after immunizationwith IRBP and examined whether
the loss of STAT3 affected the generation of this important
regulatoryCD8+ Tcell population duringEAU.We showhere
for the first time that the IL-10-producing regulatory CD8+ T
cell population is indeed recruited into peripheral lymphoid
tissues of mice during EAU (Figure 5(c)). Surprisingly, we
observed significant expansion of the IL-10-producing CD8+
T cell population in these tissues of the IRBP-immunized
CD4-STAT3KO mice, with levels more than 4-fold higher
compared to WT mice (Figure 5(c)). We also observed a
modest increase in IL-10-expressing STAT3-deficient CD4+
T cells (Figure 5(d)). CD8+ T cells were isolated from the
spleen and lymph nodes of day-21 immunized WT or CD4-
STAT3KO mice, purified by sorting on magnetic bead, and
RNA from the cells was analyzed for IL-10 expression. Result
of RT-PCR (Figure 5(e)) or RT-qPCR (Figure 5(f)) analyses
confirmed that the IRBP-immunized CD4-STAT3KO mice
contained significant levels of CD8+ T cells expressing IL-
10 mRNA compared to CD8+ T cells from the WT mice
with EAU (Figures 5(e) and 5(f)). These results uncover
a previously unrecognized role of STAT3 in CD8+ T cells
and suggest that in addition to promoting Th17 disease-
inducing activities, STAT3 activation in CD8+ T cells may
further undermine the recovery from EAU by inhibiting
the development or expansion of IL-10-producing CD8+
regulatory cells.
4. Discussion
In this study, we have characterized the role of STAT3
pathways in CD8+ T cell. Specifically, we examined whether
the loss of STAT3 affected the development of the CD8+ T cell
phenotype or its regulatory functions during HSV-1 infection
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and mouse uveitis. STAT3-deficient CD8+ T cells were found
to exhibit an activation phenotype consistent with previous
findings in STAT3-deficient CD4+ T cells [14, 22]. We also
show here that the STAT3-deficient CD8+ T cells divided
faster thanWT CD8+ T cells in response to TCR stimulation
and their enhanced cellular proliferation was accompanied
by marked increase in IL-2 production. It is however notable
that the increased production of IL-2 and high proliferative
capacity rendered the STAT3-deficient CD8+ T cells highly
susceptible to AICD.
Similar to STAT3-deficient CD4+ T cells, the enhanced
proliferation of the STAT3-deficient CD8+ T cells derived, in
part, from the downregulation of FoxO1, FoxO3A, p21waf1,
and p27KIP1. Our data further suggest that the increased
sensitivity to AICD can be attributed to reduced expression
of the antiapoptotic proteins, Bcl-2 and OX-40, and up-
regulation of the transcription of proapoptotic genes, FasL,
Bax, and Bad. Although STAT3 pathways appear to have
similar regulatory effects on CD4+ and CD8+ T cells, the
CD8 phenotype appears to be more sensitive to growth
inhibitory effects of STAT3. Despite the increased cell death
from AICD, we observed significantly higher total numbers
of STAT3-deficient Tc0 and Tc1 cells compared to the WT,
Tc0, or Tc1. During HSV-1 infection, the overall immune
response to the virus was similar between WT and CD4-
STAT3KO mice. However, the CD4-STAT3KO mice con-
tained significantly lower amounts of activated KLRG-1+
HSV-1-responsive CD8+ T cells, underscoring the important
role played by STAT3 pathways in promoting CD8+ T cell
effector responses to virus.
The production of IFN-𝛾 is a hallmark feature of CD8+
T cells. Surprisingly, the production of IFN-𝛾 was markedly
decreased in the STAT3-deficient CD8+ T cells (Figures 2(a)
and 4(d)), suggesting that STAT3may promote the expansion
of IFN-𝛾-producing Tc1 cells in vivo. This contrasts with
results from previous studies indicating that CD4-STAT3KO
mice exhibit exaggerated increase of IFN-𝛾-producing Th1
cells [7] and argues for diametrically opposite effects of
STAT3 on IFN-𝛾 expression by CD4+ and CD8+ T cells.
Thus, activation of STAT3 pathways in CD4+ T cells may
promoteTh17 development and inhibit IFN-𝛾 production by
antagonizingTh1 differentiation and expansion. On the other
hand, STAT3 pathways seem to enhance IFN-𝛾 production
in CD8+ T cells by a yet unknownmechanism. Confirmation
that STAT3 does indeed transactivate IFN-𝛾 in CD8+ T cells
will require demonstration by chromatin immunoprecipita-
tion (CHIP) assay that STAT3 binds directly to the IFN-𝛾
promoter or locus. Nonetheless, the involvement of STAT3 in
regulating IFN-𝛾 production in CD8+ T cells is supported by
our in vivo data showing a 56% increase in IFN-𝛾-expressing
CD8+ T cells in WT mice infected with HSV-1, while the
frequency of IFN-𝛾-producing CD8+ T cells in the infected
CD4-STAT3KO mice was much reduced (Figure 4(d)).
Another instance where the effect of STAT3 appears
to differ between CD4+ and CD8+ T cells is during the
recovery phase of EAU. Although there is strong consensus
that EAU and EAE are predominantly CD4+ T cell mediated
diseases, the role of CD8+ T cells has not been clear. However,
transfer of IL-10-producing CD8+ T cells into mice with
EAEdramatically diminished EAE symptoms, indicating that
CD8+ T cells play a regulatory role in the recovery from EAE
[31]. In this study, we detected IL-10-producing CD8+ T cells
in the spleen and lymphnodes ofWTEAUmice (Figure 5(c)).
However, in the STAT3KOmice that are resistant to EAU, we
observed a dramatic expansion of the IL-10-producing CD8+
regulatory T cells compared to WT (1.57% versus 6.42%).
This is the first report of the involvement of IL-10-producing
regulatory CD8+ T cells in EAU and provides confirmation
of a previous report in EAE [31].
Use of the CD4-Cre mouse strain in generating T cell-
specific conditional knockout mice has provided a wealth of
knowledge on the physiological roles of several transcription
factors in CD4+ T cells. Unfortunately, after publication of
studies utilizing these valuable mouse strains, there is often
little or no incentive to investigate its effects on CD8+ T
cells despite concomitant deletion of the gene of interest
in CD8+ T cells. This reluctance derives from the implicit
assumption that results gleaned fromCD4+ T cells would also
pertain to CD8+ T cells. In this study, we have pointed out
several crucial points that the effects of STAT3 differ between
CD4+ and CD8+ T cells. Such differences may provide
valuable insights into divergent functions of CD4+ and CD8+
T cells. For example, most focus on the role of STAT3
in autoinflammatory diseases, such as uveitis and multiple
sclerosis, has been on its involvement in the differentiation
and expansion of pathogenic Th17 cells. However, we have
shown here that IL-10-producing regulatory CD8+ T cells
are generated during EAU and significantly increased in
STAT3-deficient mice, suggesting that STAT3 also functions
to suppress this regulatory CD8+ T cell population that
plays a role in the recovery from organ-specific autoimmune
diseases. In this context, we posit that the involvement of
STAT3 activation in pathogenic mechanisms of autoimmune
and infectious diseases may not be confined to CD4+ T
cells. While STAT3-mediated expansion of Th17 cells may
initiate the acute uveitis, aberrant activation of STAT3 by IL-6
during the inflammatory process may promote development
of chronic uveitis by inhibiting expansion of CD8+ regulatory
T cells and thereby impeding recovery from the acute disease.
Thus, the recent success in ameliorating uveitis by use of small
chemical inhibitors of STAT3 [33] cannot bewholly attributed
to inhibition of Th17 cells.
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